Skip to content
Certified ManufacturersFor manufacturers

Pure Encapsulations

Sudbury, MA, United States

Due-diligence report

Find an accredited testing lab and confirm its scope covers your product and methods.

Pure Encapsulations is a dietary supplement manufacturer in Sudbury, MA, United States, certified to NSF/ANSI 455-2 GMP, with 2 manufacturing facilities on NSF’s public NSF/ANSI 455 listing as of November 19, 2026. Listed dosage forms: capsules, liquids, powders, softgels and tablets.

Facilities listed
3
Last checked

Dosage forms

As listed in the product categories of this company’s NSF/ANSI 455-2 certified facilities.

Certified facilities

Manufacturing (2)

  • 490 Boston Post Road, Sudbury, MA 01776, United States

    • Dry Formulation
    • Encapsulation
    • Mixing
    • Packaging/Labeling Operation
    • Packaging/Labeling Operation - Bulk Packaging
    • Packaging/Labeling Operation - Primary Packaging
    • Quality Unit Operations
    • Warehousing
  • 33 Union Avenue, Sudbury, MA 01776, United States

    • Quality Unit Operations
    • Warehousing

Distribution (1)

  • 33 Union Avenue, Sudbury, MA 01776, United States

    • Quality Unit Operations
    • Warehousing

How Pure Encapsulations compares

Among the 769 manufacturers we list, as of our last check.

  • The only capsule manufacturer we list in Massachusetts, out of 325 in the United States. All capsule manufacturers in the USA
  • The only tablet manufacturer we list in Massachusetts, out of 228 in the United States. All tablet manufacturers in the USA
  • The only softgel manufacturer we list in Massachusetts, out of 160 in the United States. All softgel manufacturers in the USA
  • Has 2 listed manufacturing or packaging facilities; 71% of the manufacturers we list have fewer.
  • Lists 5 dosage forms; 80% of the manufacturers we list have fewer.

FDA recall records

FDA lists 1 recall matching the name Pure Encapsulations, as of .

  • Class III · Unlikely to cause health problems

    Reported

    Closed by FDA

    Product contains undeclared sulfites.

    2 products, first listed: Pure Encapsulations Systemic Enzyme Complex DIETARY SUPPLEMENT 180 CAPSULES UPC: 7 66298 00862 2

    See all 2 products
    • Pure Encapsulations Systemic Enzyme Complex DIETARY SUPPLEMENT 180 CAPSULES UPC: 7 66298 00862 2
    • pure encapsulations AI Enzymes DIETARY SUPPLEMENT 120 CAPSULES UPC: 7 66298 00318 4 and 60 CAPSULES UPC: 7 66298 00317 7
    openFDA record

We match FDA records by company name only. A recall listed under a different name won’t appear here, and a different company with the same name could. FDA’s food enforcement records start in June 2012. How we check

FDA inspections

FDA lists 7 food or dietary supplement inspections at facilities matching Pure Encapsulations, from 2009 to 2022, as of . 4 found no objectionable conditions, 2 found conditions the firm was left to correct, and 1 led FDA to recommend official action.

  • No action indicated · No objectionable conditions found

    Inspected

    Sudbury, Massachusetts

    FEI 3000237804

  • No action indicated · No objectionable conditions found

    Inspected

    Sudbury, Massachusetts

    FEI 3000237804

  • No action indicated · No objectionable conditions found

    Inspected

    Sudbury, Massachusetts

    FEI 3000237804

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Sudbury, Massachusetts

    1 citation posted:

    • Quality control, review, approve; investigate, follow-up (21 CFR 111.560(b))
    Full citation text
    • Quality control, review, approve; investigate, follow-up (21 CFR 111.560(b))

      Your quality control personnel did not review and approve decisions about whether to investigate a product complaint.

    FEI 3000237804

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Sudbury, Massachusetts

    2 citations posted:

    • Master manufacturing record - ingredients list (21 CFR 111.210(d))
    • Examination, testing; established criteria (21 CFR 111.315(e))
    Full citation text
    • Master manufacturing record - ingredients list (21 CFR 111.210(d))

      Your master manufacturing record did not include the identity of each ingredient that will be declared on the ingredients list of the dietary supplement.

    • Examination, testing; established criteria (21 CFR 111.315(e))

      You did not follow laboratory control processes for use of test methods and examinations in accordance with established criteria.

    FEI 3000237804

Show all 7 inspections
  • No action indicated · No objectionable conditions found

    Inspected

    Sudbury, Massachusetts

    FEI 3000237804

  • No action indicated · No objectionable conditions found

    Inspected

    Sudbury, Massachusetts

    FEI 3000237804

  • No action indicated · No objectionable conditions found

    Inspected

    Sudbury, Massachusetts

    FEI 3000237804

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Sudbury, Massachusetts

    1 citation posted:

    • Quality control, review, approve; investigate, follow-up (21 CFR 111.560(b))
    Full citation text
    • Quality control, review, approve; investigate, follow-up (21 CFR 111.560(b))

      Your quality control personnel did not review and approve decisions about whether to investigate a product complaint.

    FEI 3000237804

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Sudbury, Massachusetts

    2 citations posted:

    • Master manufacturing record - ingredients list (21 CFR 111.210(d))
    • Examination, testing; established criteria (21 CFR 111.315(e))
    Full citation text
    • Master manufacturing record - ingredients list (21 CFR 111.210(d))

      Your master manufacturing record did not include the identity of each ingredient that will be declared on the ingredients list of the dietary supplement.

    • Examination, testing; established criteria (21 CFR 111.315(e))

      You did not follow laboratory control processes for use of test methods and examinations in accordance with established criteria.

    FEI 3000237804

  • Official action indicated · Regulatory or administrative action recommended

    Inspected

    Sudbury, Massachusetts

    4 citations posted:

    • In-process identity, purity, strength, composition (21 CFR 111.70(c)(1))
    • Component - verify identity, dietary ingredient (21 CFR 111.75(a)(1)(i))
    • Specifications not met - identity; component, reject (21 CFR 111.77(b))
    • Master manufacturing record - each batch (21 CFR 111.205(a))
    Full citation text
    • In-process identity, purity, strength, composition (21 CFR 111.70(c)(1))

      You did not establish in-process specifications for a point, step, or stage in the master manufacturing record where control is necessary to help ensure that specifications are met for identity, purity, strength, and composition.

    • Component - verify identity, dietary ingredient (21 CFR 111.75(a)(1)(i))

      You did not conduct at least one appropriate test or examination to verify the identity of a dietary ingredient, prior to its use.

    • Specifications not met - identity; component, reject (21 CFR 111.77(b))

      Your quality control personnel did not reject a component that did not meet an identity specification.

    • Master manufacturing record - each batch (21 CFR 111.205(a))

      You did not prepare a written master manufacturing record for each batch size of a dietary supplement that you manufactured.

    FEI 3000237804

  • No action indicated · No objectionable conditions found

    Inspected

    Sudbury, Massachusetts

    5 citations posted:

    • Specifications-component purity, strength, composition (21 CFR 111.70(b)(2))
    • Written procedures - quality control operations, reprocessin (21 CFR 111.103)
    • Master manufacturing record - Supplemental Facts (21 CFR 111.210(d))
    • Packaging description, representative label (21 CFR 111.210(g))
    See all 5 citations
    • Specifications-component purity, strength, composition (21 CFR 111.70(b)(2))

      You did not establish component specifications for strength.

    • Written procedures - quality control operations, reprocessin (21 CFR 111.103)

      You did not follow written procedures for quality control operations for approving or rejecting reprocessing.

    • Master manufacturing record - Supplemental Facts (21 CFR 111.210(d))

      Your master manufacturing record did not include the weight or measure of each dietary ingredient that will be declared on the Supplement Facts label.

    • Packaging description, representative label (21 CFR 111.210(g))

      Your master manufacturing record did not include a a representative label, or a cross-reference to the physical location of the actual or representative label.

    • Record - product complaint; nature, how used (21 CFR 111.570(b)(2)(ii)(D))

      The written record of a product complaint did not include the nature of the complaint.

    FEI 3000237804

We match FDA inspections to companies by facility ZIP code (or city outside the US) and company name, so an inspection filed under a different name won’t appear here. FDA publishes final classifications only, and holds some back while enforcement is pending. Posted citations may differ from FDA’s final findings. FDA Data Dashboard · How we check

What we checked, and what we didn’t

Confirmed from NSF’s public listing

Last checked

  • NSF/ANSI 455-2 GMP certification
  • 3 facility addresses
  • Dosage forms in the certified scope
  • Operations listed for each facility

Not verified by us

  • Minimum order quantity (MOQ): the smallest order they accept
  • Lead times and current capacity
  • Prices
  • Other certifications, like organic, kosher, halal or NSF Certified for Sport
  • Whether they’re taking new clients
  • Conditions inside the facility. We don’t visit or audit facilities.

Ask about these in your quote request. How we verify

Other capsule manufacturers in the United States

  1. NSF lists 5 capsule facilities, including one in Tempe, AZ

    Tempe, AZ, United States21stcenturyvitamins.com

    • Capsules
    • Gummies
    • Softgels
    • Tablets
    Operations:
    • Kitting
    • Coating
    • Tablet compression
    • Encapsulation
    NSF/ANSI 455-2checked Nov 19, 2026
  2. NSF lists a capsule facility in Centennial, CO

    Centennial, CO, United States5280smc.com

    • Capsules
    Operations:
    • Encapsulation
    • Dry formulation
    NSF/ANSI 455-2checked Nov 19, 2026
  3. NSF lists a capsule facility in Garden Grove, CA

    Garden Grove, CA, United Statespackaging.com

    • Capsules
    • Gummies
    • Powders
    • Softgels
    • Tablets
    NSF/ANSI 455-2checked Nov 19, 2026
  4. NSF lists a capsule facility in Ada, MI

    Ada, MI, United Statesamway.com

    • Capsules
    • Powders
    • Softgels
    • Tablets
    Operations:
    • Kitting
    • Coating
    • Tablet compression
    • Encapsulation
    • +1 more
    NSF/ANSI 455-2checked Nov 19, 2026
  5. NSF lists 2 capsule facilities, including one in Chandler, AZ

    Gilbert, AZ, United Statesadeptlifesciences.com

    • Capsules
    • Liquids
    • Powders
    • Tablets
    Operations:
    • Liquid formulation
    • Tablet compression
    • Encapsulation
    • Dry formulation
    NSF/ANSI 455-2checked Nov 19, 2026
  6. NSF lists a capsule facility in Congers, NY

    Congers, NY, United Statesadhhealth.com

    • Capsules
    • Oils
    • Powders
    • Tablets
    Operations:
    • Coating
    • Tablet compression
    • Encapsulation
    • Dry formulation
    NSF/ANSI 455-2checked Nov 19, 2026